• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

甲基转移酶样 3 介导的 RNA N-甲基腺苷促成免疫失调:诊断生物标志物与治疗靶点。

Methyltransferase-like 3-mediated RNA N-methyladenosine contributes to immune dysregulation: diagnostic biomarker and therapeutic target.

作者信息

Zhang Deshuang, Xu Ting, Gao Xiaoxue, Qu Yi, Su Xiaojuan

机构信息

Key Laboratory of Birth Defects and Related Diseases of Women and Children (Ministry of Education), West China Second University Hospital, Sichuan University, Chengdu, Sichuan, China.

Division of Neonatology, Department of Pediatrics, The Affiliated Hospital of Southwest Medical University, Luzhou, Sichuan, China.

出版信息

Front Immunol. 2025 Mar 24;16:1523503. doi: 10.3389/fimmu.2025.1523503. eCollection 2025.

DOI:10.3389/fimmu.2025.1523503
PMID:40196133
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11973086/
Abstract

Methyltransferase-like 3 (METTL3) plays a crucial role in post-transcriptional gene regulation. Substantial evidence links METTL3 to various immune dysfunctions, such as the suppression of antiviral immunity during viral infections and the disruption of immune tolerance in conditions like autoimmune diseases, myeloid leukemia, skin cancers, and anticancer immunotherapy. However, a thorough review and analysis of this evidence is currently missing, which limits the understanding of METTL3's mechanisms and significance in immune dysfunctions. This review aims to elucidate the roles and mechanisms of METTL3 in these immune issues, highlighting its connections and proposing new insights into its modulation of immune responses. Analysis results in this review suggest that METTL3 hampers antiviral immunity, worsens viral replication and infection, and disrupts immune tolerance; conversely, regulating METTL3 enhances antiviral immunity and facilitates viral clearance. Moreover, clinical data corroborates these findings, showing that METTL3 overexpression is associated with increased susceptibility to viral infections and autoimmune conditions. This review establishes a theoretical basis for considering METTL3 as a novel regulator, an important diagnostic biomarker, and a potential target for treating immune dysfunctions.

摘要

甲基转移酶样3(METTL3)在转录后基因调控中起着关键作用。大量证据表明METTL3与多种免疫功能障碍有关,如病毒感染期间抗病毒免疫的抑制以及自身免疫性疾病、髓系白血病、皮肤癌和抗癌免疫治疗等情况下免疫耐受的破坏。然而,目前缺乏对这些证据的全面综述和分析,这限制了对METTL3在免疫功能障碍中的机制和意义的理解。本综述旨在阐明METTL3在这些免疫问题中的作用和机制,强调其联系并提出对其调节免疫反应的新见解。本综述的分析结果表明,METTL3会阻碍抗病毒免疫,加剧病毒复制和感染,并破坏免疫耐受;相反,调节METTL3可增强抗病毒免疫并促进病毒清除。此外,临床数据证实了这些发现,表明METTL3过表达与病毒感染和自身免疫性疾病易感性增加有关。本综述为将METTL3视为一种新型调节剂、重要的诊断生物标志物和治疗免疫功能障碍的潜在靶点奠定了理论基础。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/28da/11973086/2fec7535dca2/fimmu-16-1523503-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/28da/11973086/e1fecaebe9d7/fimmu-16-1523503-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/28da/11973086/2fec7535dca2/fimmu-16-1523503-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/28da/11973086/e1fecaebe9d7/fimmu-16-1523503-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/28da/11973086/2fec7535dca2/fimmu-16-1523503-g002.jpg

相似文献

1
Methyltransferase-like 3-mediated RNA N-methyladenosine contributes to immune dysregulation: diagnostic biomarker and therapeutic target.甲基转移酶样 3 介导的 RNA N-甲基腺苷促成免疫失调:诊断生物标志物与治疗靶点。
Front Immunol. 2025 Mar 24;16:1523503. doi: 10.3389/fimmu.2025.1523503. eCollection 2025.
2
Methyltransferase-Like 3-Mediated N-Methyladenosine Modification on RNAs: A Novel Perspective for the Pathogenesis and Treatment of Bone Diseases.甲基转移酶样3介导的RNA N-甲基腺苷修饰:骨疾病发病机制与治疗的新视角
J Cell Mol Med. 2025 Mar;29(5):e70483. doi: 10.1111/jcmm.70483.
3
A novel interaction between RNA mA methyltransferase METTL3 and RREB1.RNA mA 甲基转移酶 METTL3 与 RREB1 之间的新相互作用。
Biochem Biophys Res Commun. 2024 Nov 12;733:150668. doi: 10.1016/j.bbrc.2024.150668. Epub 2024 Sep 10.
4
Multifaceted Roles of the -Methyladenosine RNA Methyltransferase METTL3 in Cancer and Immune Microenvironment.METTL3 在癌症和免疫微环境中的多功能 RNA m6A 甲基转移酶作用。
Biomolecules. 2022 Jul 28;12(8):1042. doi: 10.3390/biom12081042.
5
Methyltransferase-like 3 Modulates Severe Acute Respiratory Syndrome Coronavirus-2 RNA N6-Methyladenosine Modification and Replication.甲基转移酶样蛋白 3 调节严重急性呼吸综合征冠状病毒-2 RNA N6-甲基腺苷修饰和复制。
mBio. 2021 Aug 31;12(4):e0106721. doi: 10.1128/mBio.01067-21. Epub 2021 Jul 6.
6
METTL3's role in cervical cancer development through mA modification.METTL3 通过 mA 修饰在宫颈癌发生发展中的作用。
FASEB J. 2024 Jun 15;38(11):e23693. doi: 10.1096/fj.202400580.
7
Distinct pathways utilized by METTL3 to regulate antiviral innate immune response.METTL3用于调节抗病毒先天免疫反应的不同途径。
iScience. 2024 Sep 30;27(11):111071. doi: 10.1016/j.isci.2024.111071. eCollection 2024 Nov 15.
8
Diagnostic and therapeutic potentials of methyltransferase-like 3 in liver diseases.甲基转移酶样蛋白 3 在肝脏疾病中的诊断和治疗潜力。
Biomed Pharmacother. 2024 Mar;172:116157. doi: 10.1016/j.biopha.2024.116157. Epub 2024 Feb 1.
9
TBK1-METTL3 axis facilitates antiviral immunity.TBK1-METTL3 轴促进抗病毒免疫。
Cell Rep. 2022 Feb 15;38(7):110373. doi: 10.1016/j.celrep.2022.110373.
10
METTL3-mediated m6A modification enhances lncRNA H19 stability to promote endothelial cell inflammation and pyroptosis to aggravate atherosclerosis.METTL3 介导的 m6A 修饰增强 lncRNA H19 的稳定性,促进内皮细胞炎症和细胞焦亡,加重动脉粥样硬化。
FASEB J. 2024 Oct 31;38(20):e70090. doi: 10.1096/fj.202401337RR.

本文引用的文献

1
METTL3-mediated methylation of RAC2 contributes to cell motility, oxidative stress and inflammation in TNF-α-stimulated rheumatoid arthritis fibroblast-like synovial cells.METTL3介导的RAC2甲基化有助于肿瘤坏死因子-α刺激的类风湿关节炎成纤维样滑膜细胞的细胞运动、氧化应激和炎症反应。
J Orthop Surg Res. 2025 Feb 20;20(1):180. doi: 10.1186/s13018-025-05526-4.
2
mA-modified RIOK3 activated the NF-κB-signaling pathway by CDC42, promoting the replication and proliferation of enterovirus.mA修饰的RIOK3通过CDC42激活NF-κB信号通路,促进肠道病毒的复制和增殖。
Int J Biol Macromol. 2025 May;305(Pt 2):140988. doi: 10.1016/j.ijbiomac.2025.140988. Epub 2025 Feb 15.
3
Discovery, Optimization, and Preclinical Pharmacology of EP652, a METTL3 Inhibitor with Efficacy in Liquid and Solid Tumor Models.
EP652的发现、优化及临床前药理学研究,EP652是一种在液体和实体瘤模型中有效的METTL3抑制剂。
J Med Chem. 2025 Feb 13;68(3):2981-3003. doi: 10.1021/acs.jmedchem.4c02225. Epub 2025 Jan 30.
4
METTL3 facilitates kidney injury through promoting IRF4-mediated plasma cell infiltration via an m6A-dependent manner in systemic lupus erythematosus.METTL3 通过促进 IRF4 介导的浆细胞浸润促进系统性红斑狼疮中的肾脏损伤,通过 m6A 依赖的方式。
BMC Med. 2024 Nov 5;22(1):511. doi: 10.1186/s12916-024-03735-y.
5
The indispensability of methyltransferase-like 3 in the immune system: from maintaining homeostasis to driving function.甲基转移酶样蛋白 3 在免疫系统中的不可或缺性:从维持内稳态到驱动功能。
Front Immunol. 2024 Oct 2;15:1456891. doi: 10.3389/fimmu.2024.1456891. eCollection 2024.
6
Increased m6A RNA methylation and METTL3 expression may contribute to the synovitis progression of rheumatoid arthritis.m6A RNA 甲基化和 METTL3 表达增加可能有助于类风湿关节炎的滑膜炎进展。
Exp Cell Res. 2024 Oct 1;442(2):114237. doi: 10.1016/j.yexcr.2024.114237. Epub 2024 Sep 6.
7
Association between methyltransferase-like 3 and non-small cell lung cancer: pathogenesis, therapeutic resistance, and clinical applications.甲基转移酶样3与非小细胞肺癌的关联:发病机制、治疗耐药性及临床应用
Transl Lung Cancer Res. 2024 May 31;13(5):1121-1136. doi: 10.21037/tlcr-24-85. Epub 2024 May 24.
8
Diagnostic and therapeutic potentials of methyltransferase-like 3 in liver diseases.甲基转移酶样蛋白 3 在肝脏疾病中的诊断和治疗潜力。
Biomed Pharmacother. 2024 Mar;172:116157. doi: 10.1016/j.biopha.2024.116157. Epub 2024 Feb 1.
9
Methyltransferase-like 3 modifications of RNAs: Implications for the pathology in the endocrine system.甲基转移酶样 3 对 RNA 的修饰:对内分泌系统病理学的影响。
Biochim Biophys Acta Mol Basis Dis. 2024 Mar;1870(3):167010. doi: 10.1016/j.bbadis.2023.167010. Epub 2024 Jan 2.
10
Diagnosis and management of autoimmune diseases in the ICU.重症监护病房中自身免疫性疾病的诊断与治疗。
Intensive Care Med. 2024 Jan;50(1):17-35. doi: 10.1007/s00134-023-07266-7. Epub 2023 Dec 19.